Mesoblast | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Avita Medical AUD 21.23M 2.57M 2024-12
Clinuvel Pharmaceuticals AUD 16.21M 3.62M 2024-06
Cochlear AUD 465.6M 33.6M 2024-06
CSL USD 1.38B 341M 2024-06
Opthea USD 6.58M 2.62M 2024-06
Pacific Edge NZD 19.43M 12.04M 2024-09
Paradigm Biopharmaceuticals AUD 3M 774.85K 2024-06
PYC Therapeutics AUD 1.01M 851.93K 2024-06
Ramsay Health Care AUD 5.29B 3.2M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Starpharma Holdings AUD 1.82M 1.78M 2024-06
Telix Pharmaceuticals AUD 87.69M 29.72M 2024-06



Mesoblast Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.